PC12 cell line (PC12)

PC12 is a clonal cell line derived from a transplantable rat pheochromocytoma of the adrenal medulla, first established by Greene and Tischler in 1976 [1, 2, 3]. It is not a specific molecular target but rather a widely utilized in vitro model system in neurobiology and pharmacology for studying neuronal development and function [1, 4, 6]. These cells possess the biochemical machinery to synthesize, store, and release catecholamines, specifically dopamine and norepinephrine [1, 5, 8]. A defining characteristic of PC12 cells is their dramatic response to Nerve Growth Factor (NGF); upon exposure, they cease proliferation and undergo reversible differentiation into a sympathetic neuron-like phenotype, complete with neurite outgrowth and electrical excitability [1, 8, 9]. \n\nThis versatility makes PC12 cells a standard platform for modeling neurodegenerative diseases, such as Parkinson's and Alzheimer's, and for investigating mechanisms of neurotoxicity and neuroprotection [5, 7, 10]. Researchers frequently use the cell line to screen potential therapeutic compounds and evaluate their impact on signaling pathways like the Raf-MAPK cascade [2, 6, 11]. Despite their rat origin, they remain a cornerstone of neuroscience research due to their ease of culture and the extensive body of existing literature characterizing their physiological responses [6, 7].

Other names

PC-12Rat pheochromocytoma cell linePC12 AdhPheochromocytoma cell line 12

PC12 cells are an in vitro cellular model system rather than a molecular target; drugs and experimental compounds are applied to these cells to evaluate their effects on neuronal survival, phenotypic differentiation, and neurotransmitter dynamics [6, 9, 11].